Microfluidic Liposome Size Control via Flow Rate Manipulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional methods for forming liposomes result in polydisperse particles due to heterogeneous chemical and mechanical conditions during self-assembly, making it difficult to control liposome size and lamellarity, which is crucial for biological applications such as targeted drug delivery and DNA transfection.
Innovation Solution
The use of a microfluidic network with controlled fluid flow rates to create a homogenous solvent-aqueous interfacial region, allowing for precise control of liposome size by manipulating the flow rates of solvent and aqueous streams, resulting in monodisperse liposomes with diameters ranging from 100 nm to 300 nm.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional bulk phase mixing methods are used for liposome preparation, then the process is simple and easy to manufacture, but the liposomes produced are polydisperse in size and lamellarity due to heterogeneous chemical and mechanical conditions
Solution Approach 1:
The bulk mixing process is segmented into multiple microfluidic channels where solvent and aqueous streams are divided and recombined in a controlled sequence. This segmentation allows independent control of mixing zones, creating homogeneous conditions at each stage while maintaining overall process simplicity through modular channel design.
Solution Approach 2:
The invention transitions from three-dimensional bulk phase mixing to two-dimensional planar microfluidic channel flow. This dimensional reduction enables precise control of fluid interfaces and mixing conditions, creating uniform shear fields and concentration gradients that produce monodisperse liposomes while keeping the device footprint small.
2Stability of the object's composition
If bulk phase mixing is used, then the equipment and process are simple, but the chemical and mechanical conditions are highly heterogeneous on the liposome length scale
Solution Approach 1:
The invention uses hydraulic flow control through microfluidic channels to create uniform shear fields and concentration gradients. By controlling flow rates and channel geometries, homogeneous chemical and mechanical conditions are achieved during liposome self-assembly, eliminating the heterogeneity inherent in bulk mixing while maintaining manufacturability.
Solution Approach 2:
The invention changes the physical parameters of the mixing process by transitioning from bulk to microscale dimensions. This parameter change (length scale reduction) fundamentally alters the fluid dynamics, creating laminar flow conditions with predictable velocity profiles and diffusion rates that ensure homogeneous conditions throughout the mixing zone.
3Manufacturing precision
If traditional liposome preparation methods are used, then the process is straightforward, but the liposomes exhibit large polydispersity with respect to size and lamellarity
Solution Approach 1:
The microfluidic device enables continuous production of monodisperse liposomes by maintaining steady laminar flow conditions throughout the mixing channels. The continuous flow ensures consistent shear fields and concentration gradients, producing uniform liposomes at high rates without the batch-to-batch variability inherent in traditional methods.
Solution Approach 2:
The invention replaces mechanical stirring and bulk mixing with controlled hydraulic flow in microchannels. This substitution eliminates turbulent mixing and mechanical shear variability, using instead predictable laminar flow and molecular diffusion to achieve uniform liposome formation while maintaining high production throughput.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method produces liposomes with uniform size distribution and reduced polydispersity, enhancing their suitability for biological applications by mimicking controlled nanoscale synthesis environments, improving drug delivery and encapsulation efficiency.
Implementation Method 1
where the solvent stream and the at least one aqueous stream diffuse into each other to provide conditions such that liposomes self-assemble
Implementation Method 2
impinging on said solvent stream through at least one side microchannel at least one aqueous stream which hydrodynamically focuses the solvent stream
Implementation Method 3
liposomes self-assemble from the lipids or lipid-forming materials
Data Source
AI summary
Methods for the formation of liposomes that encapsulate reagents in a continuous 2-phase flow microfluidic network with precision control of size, for example, from 100 nm to 300 nm, by manipulation of liquid flow rates are described. By creating a solvent-aqueous interfacial region in a microfluidic format that is homogenous and controllable on the length scale of a liposome, fine control of liposome size and polydispersity can be achieved.